Crispr Therapeutics AG Balance Sheet
Crispr Therapeutics AG's total assets for Q4 2025 were $2.27B, an increase of 0.89% from the previous quarter. CRSP total liabilities were $343.43M for the fiscal quarter, a 4.28% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.